66316-1-Ig
antibody from Proteintech Group
Targeting: EPCAM
17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1
Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66316-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- EPCAM antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated EPCAM antibody (Cat. #66316-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IF, IHC, WB, ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 2A2D5
- Vial size
- 20ul, 150ul
Submitted references A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer.
Downregulation of NEBL promotes migration and invasion of clear cell renal cell carcinoma by inducing epithelial-mesenchymal transition.
Photo-functionalized TiO(2) film for facile immobilization of EpCAM antibodies and efficient enrichment of circulating tumor cells.
Multi-modal imaging probe for EpCAM overexpressed in breast cancer.
Spherical nucleic acids-based cascade signal amplification for highly sensitive detection of exosomes.
Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis.
miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance.
Mutations in the coat complex II component SEC23B promote colorectal cancer metastasis.
Zhang M, Zhou K, Wang Z, Liu T, Stevens LE, Lynce F, Chen WY, Peng S, Xie Y, Zhai D, Chen Q, Shi Y, Shi H, Yuan Z, Li X, Xu J, Cai Z, Guo J, Shao N, Lin Y
Cancer research 2024 Jun 4;84(11):1781-1798
Cancer research 2024 Jun 4;84(11):1781-1798
Downregulation of NEBL promotes migration and invasion of clear cell renal cell carcinoma by inducing epithelial-mesenchymal transition.
Zhao R, Liang Z, Chu J, Zheng Q, Zhao J, Tang S, Chen Q, Huang Y, Zhou X, Pan X
Pathology, research and practice 2024 Feb;254:155068
Pathology, research and practice 2024 Feb;254:155068
Photo-functionalized TiO(2) film for facile immobilization of EpCAM antibodies and efficient enrichment of circulating tumor cells.
Deng H, Liu X, Chen J, He Y, Lin L, Liu X, Chen J, Liu X
Frontiers in pharmacology 2023;14:1126602
Frontiers in pharmacology 2023;14:1126602
Multi-modal imaging probe for EpCAM overexpressed in breast cancer.
Dai Y, Tang Y, Huang W, Zhao Y, Gao X, Gu Y
Talanta 2022 Dec 1;250:123715
Talanta 2022 Dec 1;250:123715
Spherical nucleic acids-based cascade signal amplification for highly sensitive detection of exosomes.
Wang L, Deng Y, Wei J, Huang Y, Wang Z, Li G
Biosensors & bioelectronics 2021 Nov 1;191:113465
Biosensors & bioelectronics 2021 Nov 1;191:113465
Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis.
Meng X, Wang J, Zhou J, Tian Q, Qie B, Zhou G, Duan W, Zhu Y
Acta biomaterialia 2021 Jun;127:266-275
Acta biomaterialia 2021 Jun;127:266-275
miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance.
Han T, Zhang Y, Yang X, Han L, Li H, Chen T, Zheng Z
Molecular therapy. Nucleic acids 2020 Mar 6;19:1073-1085
Molecular therapy. Nucleic acids 2020 Mar 6;19:1073-1085
Mutations in the coat complex II component SEC23B promote colorectal cancer metastasis.
Yang C, Chen N, Li X, Lu D, Hou Z, Li Y, Jin Y, Gu J, Yin Y
Cell death & disease 2020 Mar 2;11(3):157
Cell death & disease 2020 Mar 2;11(3):157
No comments: Submit comment
No validations: Submit validation data